About US
Contact us
>>Back
Coumadin tablet lot recalled
- Publisher：
- Publication：2011/5/9
Bristol-Myers Squibb issues recall for one lot of 5-mg warfarin tablets due to possible superpotency.
Bristol-Myers Squibb has initiated a voluntary recall of one lot of 1,000-count bottles of Coumadin (warfarin) 5-mg tablets, the company announced in a news release. The affected lot is number 9H49374A, with an expiration date of September 30, 2012.
The company reported that this recall is a “precautionary measure”; when tablets from a returned bottle of Coumadin were tested, one tablet was found to be higher in potency than expected. The affected bottles are distributed to pharmacies, which then dispense the medications to patients in prescription quantities.
Bristol-Myers Squibb recommended that patients who have 5-mg Coumadin tablets not interrupt their therapy. Instead, they should contact their pharmacist to determine if their tablets originated from the recalled lot and, if so, consult their physician for appropriate medical advice.
Adverse reactions should be reported to FDA MedWatch. Bristol-Myers Squibb said in the news release that health professionals and patients can also contact Stericycle, Inc., at 866-918-8739 for more information about the recall.
Posted by Alex Egerváry (aegervary@aphanet.org)